{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:15:30Z","timestamp":1760832930651,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bmcl.2010.07.112","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T05:13:12Z","timestamp":1280898792000},"page":"5405-5410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2"],"prefix":"10.1016","volume":"20","author":[{"given":"Todd A.","family":"Brugel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reed W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thalia","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard M.","family":"Koether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Throner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Panko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean G.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2003","series-title":"Burger\u2019s Medicinal Chemistry and Drug Discovery","author":"Aldrich","key":"10.1016\/j.bmcl.2010.07.112_b0005"},{"key":"10.1016\/j.bmcl.2010.07.112_b0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pharmthera.2009.05.008","volume":"123","author":"Carlezon","year":"2009","journal-title":"Pharm. Therap."},{"key":"10.1016\/j.bmcl.2010.07.112_b0020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.bmcl.2010.07.112_b0025","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bmcl.2010.07.112_b0030","doi-asserted-by":"crossref","unstructured":"Brugel, T. A.; Smith, R. W.; Balestra, M.; Becker, C.; Daniels, T.; Hoerter, T. N.; Koether, G. M.; Throner, S. R.; Panko, L. M.; Folmer, J. J.; Cacciola, J.; Hunter, A. m.; Liu, R.; Edwards, P. D.; Brown, D. G.; Gordon, J.; Ledonne, N. C.; Pietras, M.; Schroeder, P.; Sygowski, L. A.; Hirata, L. T.; Zacco, A.; Peters, M. F. Bioorg. Med. Chem. Lett. 2010. doi:10.1016\/j.bmcl.2010.07.113.","DOI":"10.1016\/j.bmcl.2010.07.113"},{"key":"10.1016\/j.bmcl.2010.07.112_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1087057102239667","volume":"8","author":"Schroeder","year":"2003","journal-title":"J. Biomol. Screening"},{"key":"10.1016\/j.bmcl.2010.07.112_b0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000400345","volume":"4","author":"Schwyzer","year":"1977","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.bmcl.2010.07.112_b0065","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/BF02532369","volume":"21","author":"Metzger","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bmcl.2010.07.112_b0075","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1016\/0040-4039(95)01785-G","volume":"36","author":"Gaffar","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bmcl.2010.07.112_b0080","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jm900488k","volume":"52","author":"Nagase","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2010.07.112_b0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/00397919408011310","volume":"24","author":"Tschaen","year":"1994","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bmcl.2010.07.112_b0100","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/j.bmcl.2004.04.039","volume":"14","author":"Dolle","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2010.07.112_b0105","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0960-894X(01)00278-5","volume":"11","author":"Wentland","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2010.07.112_b0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0960-894X(01)00014-2","volume":"11","author":"Wentland","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X10010814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X10010814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:17:10Z","timestamp":1760768230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X10010814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":14,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0960894X10010814"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2010.07.112","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2010.07.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}